Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:antidote |
gptkb:sugammadex
|
| gptkbp:ATCCode |
gptkb:M03AC09
|
| gptkbp:brand |
gptkb:rocuronium_bromide
|
| gptkbp:CASNumber |
gptkb:119302-91-9
|
| gptkbp:contraindication |
hypersensitivity to rocuronium
|
| gptkbp:drugClass |
non-depolarizing neuromuscular blocker
|
| gptkbp:duration |
intermediate
|
| gptkbp:eliminationHalfLife |
1.4–2.4 hours
|
| gptkbp:excretion |
urine
|
| https://www.w3.org/2000/01/rdf-schema#label |
Zemuron
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Organon
|
| gptkbp:metabolism |
liver
|
| gptkbp:onset |
gptkb:fire
|
| gptkbp:pregnancyCategory |
Category B (US)
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
allergic reaction
hypotension tachycardia |
| gptkbp:usedFor |
muscle relaxation during surgery
facilitation of tracheal intubation |
| gptkbp:bfsParent |
gptkb:rocuronium
|
| gptkbp:bfsLayer |
6
|